We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Relation Between Renin-Angiotensin Gene Polymorphisms, Plasma Adiponectin and Arterial Stiffness in Renal Transplant Recipients

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00221533
First Posted: September 22, 2005
Last Update Posted: December 28, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University Hospital, Ghent
September 12, 2005
September 22, 2005
December 28, 2007
March 2004
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00221533 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Relation Between Renin-Angiotensin Gene Polymorphisms, Plasma Adiponectin and Arterial Stiffness in Renal Transplant Recipients
Relation Between Renin-Angiotensin Gene Polymorphisms, Plasma Adiponectin and Arterial Stiffness in Renal Transplant Recipients
Relation between Renin-Angiotensin Gene Polymorphisms, Plasma Adiponectin and Arterial Stiffness in Renal Transplant Recipients
Not Provided
Observational
Time Perspective: Prospective
Not Provided
Not Provided
Not Provided
Not Provided
  • Vascular Diseases
  • Arterial Stiffness
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
250
August 2006
Not Provided

Inclusion Criteria:

  • Aged between 18 and 80 years, extremes included
  • Kidney transplants with or without other transplant organs
  • Informed consent
  • Stable clinical condition on the basis of a pre-trial physical examination, medical history, and the results of blood biochemistry and haematology tests

Exclusion Criteria:

  • Pregnant, lactating females
  • Recent (< 4 weeks) change in antihypertensive drug medication
  • Current or recent (< 2 weeks) acute illness such as infection or bleeding
  • Current treatment for malignancy
Sexes Eligible for Study: All
18 Years to 80 Years   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Belgium
 
 
NCT00221533
2005/196
No
Not Provided
Not Provided
Not Provided
University Hospital, Ghent
Not Provided
Principal Investigator: Francis Verbeke, MD University Hospital, Ghent
University Hospital, Ghent
December 2007